2009
- 2009/06/17
- Takara Bio Inc. to supply RetroNectin® to U.S. and Europe for multicentre clinical trials of gene therapy targeting X-linked Severe Combined Immunodeficiency (X-SCID)
- 2009/06/04
- Takara Bio and Kohjin-bio form an alliance in the field of cell culture media
- 2009/05/12
- Announcement of Takara Bio's mid-term management plan
- 2009/04/22
- National Cancer Center in Japan gains a regulatory approval of the clinical research for HSV-TK "haplo add-back" gene therapy in treatment of leukemia
